Literature DB >> 6102295

Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer.

T J Powles, R C Coombes, I E Smith, J M Jones, H T Ford, J C Gazet.   

Abstract

Overall survival of patients with primary breast cancer has not improved in the past ten years, despite increasing use of multiple-drug chemotherapy for treatment of metastases. Furthermore, there has been no improvement in survival from first metastasis, and survival may even have been shortened in some patients given chemotherapy. Chemotherapy probably does prolong survival in some patients, and further studies should be undertaken to identify these patients in advance.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6102295     DOI: 10.1016/s0140-6736(80)91066-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  32 in total

Review 1.  Treatment of breast cancer in the 1990s. What does the future hold?

Authors:  R B Jones; E J Shpall
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

2.  Factors influencing the response and survival of patients with liver metastases from breast cancer receiving OK-432-combined adoptive immunotherapy.

Authors:  S Yamasaki; T Okino; N Kan; K Satoh; K Mise; Y Teramura; T Harada; H Kodama; T Hori; K Ohgaki
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

3.  Primary medical treatment in breast cancer.

Authors:  Z Rayter; R F Phipps
Journal:  BMJ       Date:  1991-01-05

Review 4.  Cytotoxic chemotherapy for common adult malignancies: "the emperor's new clothes" revisited?

Authors:  J H Kearsley
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-04

5.  Aggressive or non-aggressive tumor therapy.

Authors:  P Reizenstein
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

6.  Controversies in the medical management of breast cancer.

Authors:  I E Smith
Journal:  Postgrad Med J       Date:  1985-02       Impact factor: 2.401

7.  Mitoxantrone combined to vincristine, cyclophosphamide and fluorouracil in advanced breast cancer.

Authors:  R Metz; M Delgado; R Keiling; P Cappelaere; J P Armand; G Prevot; J L Misset; J Grimbert; G Mathe
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

8.  Adjuvant chemotherapy of breast cancer: hope--reality--hazard?

Authors:  H Vorherr
Journal:  Klin Wochenschr       Date:  1984-02-15

9.  Pathobiology of breast cancer: hypothesis of biological predetermination and long-term survival.

Authors:  H Vorherr
Journal:  Klin Wochenschr       Date:  1981-08-03

Review 10.  The current and future place of vinorelbine in cancer therapy.

Authors:  E Cvitkovic; J Izzo
Journal:  Drugs       Date:  1992       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.